Toth Financial Advisory’s GSK GSK Stock Holding History

Toth Financial Advisory’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$996	Hold	19	–	–	﹤0.01%	838
2026 Q1	$1.05K	Hold	19	–	–	﹤0.01%	808
2025 Q4	$932	Buy	+19	New	+$886	﹤0.01%	787
2025 Q3	–	Sell	-45	Closed	-$1.73K	–	790
2025 Q2	$1.73K	Sell	45 -499	-92%	-$19.1K	﹤0.01%	655
2025 Q1	$21.1K	Hold	544	–	–	﹤0.01%	399
2024 Q4	$18.4K	Hold	544	–	–	﹤0.01%	407
2024 Q3	$22.2K	Hold	544	–	–	﹤0.01%	371
2024 Q2	$20.9K	Hold	544	–	–	﹤0.01%	389
2024 Q1	$23.3K	Sell	544 -100	-16%	-$4.12K	﹤0.01%	375
2023 Q4	$23.9K	Buy	644 +100	+18%	+$3.59K	﹤0.01%	368
2023 Q3	$19.7K	Hold	544	–	–	﹤0.01%	371
2023 Q2	$19.4K	Sell	544 -20	-4%	-$717	﹤0.01%	393
2023 Q1	$20.1K	Hold	564	–	–	﹤0.01%	383
2022 Q4	$19.8K	Hold	564	–	–	﹤0.01%	378
2022 Q3	$17K	Sell	564 -28	-5%	-$1.06K	﹤0.01%	392
2022 Q2	$32K	Buy	592 +32	+6%	+$1.77K	0.01%	323
2022 Q1	$30K	Buy	+560	New	+$30.4K	﹤0.01%	336
2021 Q2	–	Sell	-80	Closed	-$4K	–	713
2021 Q1	$4K	Buy	+80	New	+$3.63K	﹤0.01%	530
2020 Q3	–	Sell	-14	Closed	-$1K	–	571
2020 Q2	$1K	Buy	+14	New	+$718	﹤0.01%	504

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Toth Financial Advisory's GSK Position: Q2 2026 in Review

Toth Financial Advisory held its GSK (GSK) position steady in Q2 2026 at 19 shares worth $996. The position accounts for ﹤0.01% of the portfolio, ranked #838.

Toth Financial Advisory first reported a position in GSK in Q2 2020 and has held it in 19 quarters since. The position peaked at $32K in Q2 2022. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Toth Financial Advisory held 19 shares of GSK worth $996 as of Q2 2026.
Toth Financial Advisory left its GSK share count unchanged in Q2 2026.
GSK made up ﹤0.01% of Toth Financial Advisory's portfolio in Q2 2026, its #838 holding.
Toth Financial Advisory first reported a position in GSK in Q2 2020 and has held it in 19 quarters since.
Toth Financial Advisory's GSK position peaked at $32K in Q2 2022.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Toth Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.